NCT07358182
- Conditions
- HER2-low Breast Cancer, HER2-positive Breast Cancer, Trastuzumab-rezetecan
- Locations
-
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
Clinical trial condition
Trastuzumab-rezetecan
Explore clinical trials studying Trastuzumab-rezetecan. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study